Skip to content Skip to sidebar Skip to footer


Nucleai Expands Leadership Team and Scientific Advisory Board with Pharmaceutical Industry Experts

TEL AVIV, Israel, May 24, 2023--(BUSINESS WIRE)--Nucleai, a leader in AI-powered spatial biology, today announced the two key appointments to its leadership team and scientific advisory board. Pharmaceutical industry veteran Oscar Puig, Ph.D. has been named the VP of Translational Medicine & Diagnostics at Nucleai, while Suzana Couto, the Head of Pathology at Neomorph Inc,…

Read More

PathAI to Present on AI-based Models to Advance Tumor Analysis and Oncology Drug Development at American Association for Cancer Research Annual Meeting 2023

Latest research underscores advantages of digital tools at scale to enhance tumor microenvironment and biomarker understanding in non-small cell lung cancer and renal cell carcinoma BOSTON, Mass. , April 11, 2023 /PRNewswire/ -- PathAI, a leading provider of AI-powered pathology tools to advance precision medicine, today announced their recent research will be presented at…

Read More